These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9-26 years in the United States. March 2007.

The 2006 revision of the General Recommendations features visual elements, such as diagrams, images, tables. Following are some of the more notable additions: (1) an updated table of contraindications and precautions to commonly used vaccines, (2) images displaying the correct administration site for intramuscular and subcutaneous injections for infants and adults, (3) a table outlining the treatment of anaphylaxis, (4) a table comparing the advantages and disadvantages of various types of thermometers used to monitor vaccine storage temperatures, and much more.

The 2006 revision of the General Recommendations features visual elements, such as diagrams, images, tables. Following are some of the more notable additions: (1) an updated table of contraindications and precautions to commonly used vaccines, (2) images displaying the correct administration site for intramuscular and subcutaneous injections for infants and adults, (3) a table outlining the treatment of anaphylaxis, (4) a table comparing the advantages and disadvantages of various types of thermometers used to monitor vaccine storage temperatures, and much more.